Key result
Ivabradine administration in mice with acute Chagas disease caused QTc and QRS enlargement and was associated with supraventricular and ventricular arrhythmias.
Why the study?
Sudden death can occur unexpectedly in Chagas disease, and the role of pacemaker-current HCN4 channels in chagasic arrhythmias is not clear.
Does ivabradine alter ECG parameters and arrhythmogenesis in a mouse model of acute Chagas disease myocarditis?
Does ivabradine alter ECG parameters and arrhythmogenesis in a mouse model of acute Chagas disease myocarditis?
In a mouse model of acute Chagas disease, HCN4 overexpression leads to an over-response to ivabradine, causing arrhythmias and suggesting caution with its use in this population.
Suggests caution with ivabradine in acute Chagas myocarditis; leaves open HCN4-driven arrhythmogenesis in humans.
Chagas disease principally affects Latin-American people, but it currently has worldwide distribution due to migration. Death among those with Chagas disease can occur suddenly and without warning, even in those who may not have evidence of clinical or structural cardiac disease and who are younger than 60 years old. HCN4 channels, one of the principal elements responsible for pacemaker currents, are associated with cardiac fetal reprogramming and supraventricular and ventricular arrhythmias, but their role in chagasic arrhythmias is not clear. We found that a single-dose administration of ivabradine, which blocks HCN4, caused QTc and QRS enlargement and an increase in P-wave amplitude and was associated with ventricular and supraventricular arrhythmias in mice challenged with isoproterenol, a chronotropic/ionotropic positive agent. Continuous treatment with ivabradine did not alter the QTc interval, but P-wave morphology was deeply modified, generating supraventricular arrhythmias. In addition, we found that repolarization parameters improved with ivabradine treatment. These effects could have been caused by the high HCN4 expression observed in auricular and ventricular tissue in infected mice. Thus, we suggest, for the first time, that molecular remodeling by overexpression of HCN4 channels may be related to supraventricular arrhythmias in acute Chagas disease, causing ivabradine over-response. Thus, ivabradine treatment should be administered with caution, while HCN4 overexpression may be an indicator of heart failure and/or sudden death risk.
No takes yet. Share an insight, caveat, or question.
Rodríguez‐Angulo et al. (2021) studied Acute Chagas Disease Myocarditis. Ivabradine was evaluated on Electrocardiographic parameters and arrhythmias. Ivabradine administration in mice with acute Chagas disease caused QTc and QRS enlargement and was associated with supraventricular and ventricular arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: